BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30648121)

  • 1. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines.
    Lei WY; Hsiung SC; Wen SH; Hsieh CH; Chen CL; Wallace CG; Chang CC; Liao SK
    J Immunol Res; 2018; 2018():8363265. PubMed ID: 30648121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
    Hsieh CH; Hsu YJ; Chang CC; Liu HC; Chuang KL; Chuang CK; Pang ST; Hasumi K; Ferrone S; Liao SK
    Cancer Immunol Immunother; 2009 Mar; 58(3):395-408. PubMed ID: 18704411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
    Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
    Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.
    Thuring C; Follin E; Geironson L; Freyhult E; Junghans V; Harndahl M; Buus S; Paulsson KM
    Br J Cancer; 2015 Sep; 113(6):952-62. PubMed ID: 26313662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
    Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
    Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
    Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
    Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
    Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
    Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.
    Tanaka K; Tsuchikawa T; Miyamoto M; Maki T; Ichinokawa M; Kubota KC; Shichinohe T; Hirano S; Ferrone S; Dosaka-Akita H; Matsuno Y; Kondo S
    Int J Oncol; 2012 Apr; 40(4):965-74. PubMed ID: 22134332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
    Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
    Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
    Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
    Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma.
    Matsui M; Machida S; Itani-Yohda T; Akatsuka T
    J Gastroenterol Hepatol; 2002 Aug; 17(8):897-907. PubMed ID: 12164966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
    Yan WH; Lin AF; Chang CC; Ferrone S
    Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.